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Abstract 
Despite widespread belief that moods are affected by the menstrual cycle, researchers on 
emotion and reward have not paid much attention to the menstrual cycle until recently.  
However, recent research has revealed different reactions to emotional stimuli and to rewarding 
stimuli across the different phases of the menstrual cycle.  The current paper reviews the 
emerging literature on how ovarian hormone fluctuation during the menstrual cycle modulates 
reactions to emotional stimuli and to reward.  Behavioral and neuroimaging studies in humans 
suggest that estrogen and progesterone have opposing influences.  That is, it appears that 
estrogen facilitates reactions to reward, but progesterone counters the facilitative effects of 
estrogen and inhibits reactions to rewards.  In contrast, reactions to emotionally arousing stimuli 
(particularly negative stimuli) appear to be inhibited by estrogen but facilitated by progesterone.  
Potential factors that can modulate the effects of the ovarian hormones (e.g., an inverse quadratic 
function of hormones’ effects; the structural changes of the hippocampus across the menstrual 
cycle) are also discussed. 
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In life, we often encounter hedonic stimuli, such as happy faces, appealing animals, money, 
car accidents, and stressful events.  These hedonic stimuli sometimes induce strong 
physiological arousal (i.e., emotional arousal) that modulates subsequent cognitive processing 
(for a review see Mather & Sutherland, 2011).  Some hedonic stimuli (e.g., money; high-calorie 
foods) can also serve as reinforcers (i.e., reward), increasing the frequency of behaviors that lead 
to their acquisition with strong 'wanting' motivations (e.g., Berridge, 2003; Kringelbach, 2005).  
Given the importance of these stimuli in our life, reward and emotion have been intensively 
examined in many fields, such as social neuroscience, cognitive science, affective neuroscience, 
behavioral economics, and neuroeconomics. 
While traditional studies in these areas examined common patterns across different people 
regardless of their sex, a growing body of research demonstrates sex differences in how people 
react to and process rewards and emotional stimuli (see Andreano & Cahill, 2009; Cahill, 2006; 
Caldú & Dreher, 2007; Hamann & Canli, 2004; Kajantie & Phillips, 2006; Kudielka & 
Kirschbaum, 2005 for reviews).  One possible reason for these sex differences is that ovarian 
hormones alter reactions to emotional stimuli and to rewards.  For example, the same emotional 
stimuli may induce different arousal reactions and neural responses in brain regions modulating 
arousal depending on ovarian hormone levels.  Brain regions involved in reward processing 
might also respond differently depending on ovarian hormone levels.  To address these 
possibilities, in the current paper, we review behavioral and neuroimaging findings on the effects 
of the menstrual cycle on reactions to emotional stimuli and to rewards. 
Before further discussing the effects of ovarian hormones, we first describe our definitions 
of emotion and reward.  Emotion has been conceptualized based on two orthogonal dimensions 
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(Russell & Carroll, 1999): valence (positive or negative) and physiological arousal.  Previous 
studies revealed that the amygdala, which is a key region for emotion (Phelps & LeDoux, 2005), 
activates depending on the intensity of physiological arousal induced by a stimulus, irrespective 
of whether it is positive or negative (Anderson et al., 2003; Kensinger & Corkin, 2004; Shabel & 
Janak, 2009).  Thus, physiological arousal seems to be a critical aspect of emotion (e.g., Phelps, 
2006). 
In contrast, reward has been defined as an instrumental reinforcer which increases the 
frequency of behaviors contingent with it (e.g., Caldú & Dreher, 2007; Kringelbach, 2005; Rolls, 
2009).  Reward is not a unitary concept and has been decomposed into two aspects (Berridge & 
Robinson, 2003; Berridge, Robinson, & Aldridge, 2009): a) hedonic consequences of 
consumption ('liking') and b) incentive salience (i.e., 'wanting'; craving).  These subcategories 
suggest that rewards overlap with emotional stimuli (particularly emotionally positive stimuli), as 
rewards can produce emotional consequences (e.g., earning money could be a reinforcer but 
might also evoke emotional arousal). 
However, emotional stimuli do not always serve as reinforcers and do not necessarily have 
strong incentive salience.  For example, seeing people cerebrating their victory at the Olympics 
can induce emotional arousal, but does not necessarily alter one's behavior or induce craving for 
victory.  In addition, while the amygdala has been implicated in emotional arousal (e.g., Phelps, 
2006), reward has been associated with the striatum (including nucleus accumbens), global 
pallidum, and mesocortical dopaminergic system, such as the ventral tegmental area (Berridge, 
2003; Berridge et al., 2009), but not necessarily with the amygdala (Clarke, Robbins, & Roberts, 
2008; Murray, 2007).   
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Based on these findings, we use the term "emotional stimuli" to refer to hedonic stimuli 
that induce physiological arousal (regardless of positive or negative valence), affecting 
cardiovascular activity, heart rate, skin response, and pupil dilation.  In contrast, "reward" is 
defined as a positive reinforcer which increases the frequency of contingent behaviors while 
evoking feelings of ‘wanting’ or craving.  Emotional stimuli induce multiple reactions, 
including physiological arousal, stress hormones, amygdala activity, and subjective feelings.  
Similarly, rewards can alter physiological states (e.g., heart rate), activity in reward-related 
regions in the brain, and subjective experiences.  In the current paper, we review the effects of 
ovarian hormones without discriminating these different aspects of reactions. 
arian Hormone Changes across Menstrual Cycle 
The human menstrual cycle lasts 28 days on average and is divided into follicular and 
luteal phases.  The follicular phase begins with the onset of menstruation on day 1 and continues 
until ovulation (typically on day 14), and the luteal phase begins at ovulation and continues until 
the onset of menstruation (typically days 15-28; Figure 1).   
The early follicular phase begins with release of gonadotropin-releasing hormone from the 
hypothalamus, which stimulates the anterior pituitary to secrete follicle-stimulating hormone 
(FSH: Barr, 1999; Raven, Johnson, Singer, & Losos, 2005; Rimsza, 2002).  FSH stimulates the 
growth of a number of ovarian follicles that secrete estrogen as they get mature.  When one of 
the developing follicles becomes dominant, it starts to secrete large amounts of estrogen.  This 
sharp increase in estrogen, then, causes positive feedback effects on the hypothalamus and the 
pituitary gland, which results in a surge of luteinizing hormone (LH) and then ovulation.  
During the luteal phase, the postovulatory dominant ovarian follicle transforms into a corpus 
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luteum, which in turn produces both progesterone and estrogen.  The combination of these two 
ovarian hormones helps the endometrium thicken and become more vascular.  If fertilization 
does not occur, the corpus luteum cannot survive.  As the corpus luteum regresses, estrogen and 
progesterone levels drop and FSH begins to rise to initiate follicular growth for the next cycle. 
Thus, the absolute levels of estrogen and progesterone, and the ratio of these hormone 
concentrations, change over the regular menstrual cycle.  Both progesterone and estrogen levels 
are low during the early follicular phase, while the late follicular phase is characterized by a 
marked increase in secretion of estrogen.  Finally, progesterone levels rise during the early luteal 
phase, peaking in the mid-luteal phase, in parallel with a second estrogen peak.   
amining Effects of Ovarian Hormones in Research 
Although estrogen and progesterone are best known for their effects on the female 
reproductive organs (e.g., uterus; ovary), they cross the blood-brain barrier (Henderson, 1997; 
Wirth, 2011) and affect brain functions as well (e.g., McEwen, 2002).  For example, the 
hypothalamus, which plays an important role in regulation of the menstrual cycle (as described 
above), has both estrogen and progesterone receptors.  Many other brain regions that are not 
crucial for reproduction also show progesterone receptor expression (Brinton et al., 2008), such 
as the amygdala, brainstem, hippocampus, cerebellum, and frontal cortex.  Among those areas, 
the amygdala is a key region in emotional processing (e.g., Phelps, 2006).  The amygdala also 
has both ERα and ERβ estrogen receptors (e.g., Weiser, Foradori, & Handa, 2008).  In fact, the 
amygdala has one of the highest densities of estrogen receptors in the brain (Merchenthaler, Lane, 
Numan, & Dellovade, 2004; Shughrue & Merchenthaler, 2001).  These findings suggest that 
both estrogen and progesterone influence reactions to emotional stimuli.  In addition, other brain 
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regions, such as the ventral tegmental area, hippocampus, and cerebellum, also express at least 
one of the estrogen receptors (McEwen, 2002; Weiser et al., 2008).  Given that the ventral 
tegmental area plays a crucial role in processing of reward (Berridge, 2003; Berridge et al., 2009), 
females may show different responses to reward depending on the cycle. 
To address these effects of the ovarian hormones in humans, past studies categorized the 
menstrual cycle into several phases and compared women's reactions to emotional or rewarding 
stimuli in one phase with other phases.  Some studies distinguished the follicular vs. luteal 
phases.  Given that both estrogen and progesterone levels are higher in the luteal than in the 
follicular phase on the average, however, these studies cannot discriminate the effects of estrogen 
and progesterone.  Thus, other studies have defined menstrual phase more specifically, with 
smaller ranges of dates of testing.  For example, studies examining the effects of estrogen 
compare females in the late follicular mid-cycle phase (high estrogen and low progesterone) with 
the early follicular phase (low estrogen and low progesterone).  In contrast, studies addressing 
the effects of progesterone compare the luteal phase (high estrogen and high progesterone) vs. the 
late follicular phase (high estrogen and low progesterone).  Furthermore, researchers sometimes 
administer progesterone or estrogen to females in the early follicular phase.  The exogenous 
administration of the ovarian hormones seems especially useful to understand the role of 
progesterone independently from estrogen, because there is no phase involving low estrogen and 
high progesterone in the regular menstrual cycle. 
The phases of the cycle have been defined in various ways.  Some studies have relied on 
self-reports of the dates of menstruation.  Other studies have identified the day of ovulation by 
having participants measure their body temperature or their urinary LH levels.  Given possible 
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individual differences and potential menstrual cycle variations within the same women (e.g., 
Alliende, 2002), these methods are sometimes combined with hormone assays based on plasma 
or saliva samples to verify the definition of the phase.  While these methodological issues are 
important (see Terner & de Wit, 2006 for a related discussion), the field is new and the number of 
relevant studies is still small.  Therefore, we review studies irrespective of the methods used to 
define and verify the cycle phases. 
In the following sections, we first describe findings from past studies examining the effects 
of the menstrual cycle on reactions to rewards, and then findings on reactions to emotionally 
arousing stimuli in healthy women.  Each section starts with reviewing previous studies that 
simply compared the follicular phase (days 1-14) and the luteal phase (days 15-28).  To 
understand the roles of estrogen and progesterone, we then describe studies examining the effects 
of these hormones separately with finer cycle categorizations or exogenous administrations of the 
ovarian hormones. 
fects of Ovarian Hormones on Reactions to Reward 
Females showed greater physiological and subjective effects of cocaine (Evans & Foltin, 
2006; Evans, Haney, & Foltin, 2002), amphetamine (Justice & de Wit, 1999) and nicotine (Gray 
et al., 2010) during the follicular phase than during the luteal phase.  Neuroimaging research 
also revealed that monetary reward induced greater activity in the striatum in the follicular than 
luteal phase (Dreher et al., 2007).  However, it is not clear whether the decreased reactions to 
reward during the luteal phase were due to estrogen or progesterone, both of which are elevated 
in this period.  To address this question, we review studies examining the effects of these 
hormones separately. 
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Estrogen Facilitates Reactions to Reward  
Animal studies suggest that estrogen facilitates reactions to rewards (Becker & Hu, 2008; 
Lynch, Roth, & Carroll, 2002).  In one study (Hu, Crombag, Robinson, & Becker, 2004), for 
example, female ovariectomized rats were given estrogen before self-administration sessions, in 
which they were allowed to nose poke to obtain a cocaine infusion.  The results indicated that 
ovariectomized rats with estrogen self-administered larger amounts of cocaine more frequently 
than did ovariectomized rats without estrogen.  Estrogen was also revealed to increase 
behavioral sensitization (Becker & Hu, 2008; Galankin, Shekunova, & Zvartau, 2010; Hu & 
Becker, 2003) and dopamine release in reward-related regions in the brain (e.g., striatum; Becker, 
1990). 
Studies in humans demonstrated similar enhancement effects of estrogen on reactions to 
rewards.  When receiving doses of d-amphetamine, for instance, females reported that they liked 
the effects of drug more strongly in the late follicular phase (high estrogen and low progesterone) 
than the early follicular phase (low estrogen and low progesterone; Justice & De Wit, 2000a).  
In addition, exogenous estrogen administration to females with low progesterone increased 
subjective effects of d-amphetamine (e.g., "want more"; feeling "high"; Justice & de Wit, 2000b; 
Lile, Kendall, Babalonis, Martin, & Kelly, 2007).  Taken together with findings from animal 
studies, it appears that estrogen facilitates reactions to reward stimuli. 
Progesterone Counters Facilitative Effects of Estrogen 
However, estrogen no longer has facilitative effects on reactions to rewards when 
progesterone is high.  As described in previous sections, estrogen administration to 
ovariectomized female rats increased self-administration of cocaine (e.g., Hu et al., 2004).  
 
Running head: EMOTION, REWARD, MENSTRUAL CYCLE 10
 
When estrogen and progesterone were given together, however, progesterone diminished the 
facilitative effects of estrogen (Jackson, Robinson, & Becker, 2006; Larson, Anker, Gliddon, 
Fons, & Carroll, 2007).  These results are consistent with recent findings that progesterone 
down-regulates the estrogen receptor (e.g,. Aguirre, Jayaraman, Pike, & Baudry, 2010), and 
suggest that progesterone counters the facilitative effects of estrogen (Anker, Larson, Gliddon, & 
Carroll, 2007; Quinones-Jenab & Jenab, 2010; Yang, Zhao, Hu, & Becker, 2007). 
Studies in humans provide additional support that progesterone opposes the effects of 
estrogen.  In line with the facilitative roles of estrogen, estrogen level was positively correlated 
with the magnitude of subjective (e.g., feeling "high"; elation) and physiological (e.g., heart rate) 
stimulation of amphetamine during the follicular phase (Justice & de Wit, 1999; White, Justice, & 
de Wit, 2002).  But when progesterone was high (i.e., during the luteal phase), the level of 
estrogen no longer had a positive correlation with the magnitude of amphetamine’s stimulation 
(Justice & de Wit, 1999; White et al., 2002). 
A recent neuroimaging study also reported consistent evidence (Frank, Kim, Krzemien, & 
Van Vugt, 2010).  In this study, female participants viewed images of high-calorie-rewarding 
foods (e.g., cakes, cookies, ice cream) and of low-calorie foods (e.g., steamed vegetables) when 
they were hungry.  During the late follicular phase, high-calorie foods induced greater activity in 
reward-related regions (e.g., nucleus accumbens) than did low-calorie foods.  However, nucleus 
accumbens activity did not differ between high- and low-calorie foods in the luteal phase.  
Given the hormone patterns of the late follicular (high estrogen and low progesterone) and the 
luteal phase (high estrogen and high progesterone), these results seem consistent with the idea 
that progesterone counters facilitative effects of estrogen. 
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Progesterone Inhibits Reactions to Reward by Itself 
In addition to its countering effects on estrogen, past studies have revealed that 
progesterone can inhibit reactions to reward even when estrogen is low (Evans, 2007; 
Quinones-Jenab & Jenab, 2010).  While intact animals show strong preference for a chamber 
associated with cocaine, for example, progesterone administration diminished the preference for 
the cocaine-paired chambers in ovariectomized female rats (Russo et al., 2003) and in male rats 
(Romieu, Martin-Fardon, Bowen, & Maurice, 2003).  Studies in humans also reported similar 
findings.  When progesterone was administered to females with low estrogen, for instance, it 
attenuated physiological and subjective (e.g., feeling "high," "willing to pay") effects of cocaine 
(Evans & Foltin, 2006; Sofuoglu, Babb, & Hatsukami, 2002).  Administration of progesterone 
also reduced urges to smoke cigarettes in female smokers during the early follicular phase 
(Sofuoglu, Mouratidis, & Mooney, 2011).  Because those studies addressed the effects of 
progesterone when estrogen is low, they suggest that progesterone inhibits reactions to rewards 
not only by countering the effects of estrogen, but also by itself. 
Summary 
In summary, it appears that estrogen and progesterone have opposing effects on reactions to 
rewards.  That is, both animal and human studies indicate that estrogen facilitates reactions to 
rewards.  In contrast, studies suggest that progesterone counters the facilitative effects of 
estrogen and inhibits reactions to rewards.  As we described above, females tend to show 
increased reactions to rewards during the follicular phase than the luteal phase (Dreher et al., 
2007; Evans & Foltin, 2006; Evans et al., 2002; Gray et al., 2010; Justice & de Wit, 1999; 
Sofuoglu, Dudish-Poulsen, Nelson, Pentel, & Hatsukami, 1999).  Given studies reviewed in this 
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section, it appears that progesterone is crucial to explain the decreased reward sensitivity during 
the luteal phase. 
fects of Ovarian Hormones on Reactions to Emotionally Negative Stimuli 
Next, we turn to the question whether and how ovarian hormones influence reactions to 
emotionally arousing stimuli.  As we mentioned above, emotional stimuli involve stimuli 
inducing physiological arousal, irrespective of valence.  However, the majority of past studies 
on ovarian hormones employed only negative and neutral stimuli.  Therefore, we focus on 
findings about reactions to negative stimuli in this section. 
As in reward, previous studies revealed that females react to emotionally negative stimuli 
differently in follicular vs. luteal phases.  Compared with the follicular phase, for example, 
females in the luteal phase showed increased stress hormones after stressful tasks (Altemus, Roca, 
Galliven, Romanos, & Deuster, 2001; Childs, Dlugos, & De Wit, 2010; Kirschbaum, Kudielka, 
Gaab, Schommer, & Hellhammer, 1999; Roca et al., 2003; Tersman, Collins, & Eneroth, 1991), 
showed stronger amygdala activity when anticipating pain (Choi et al., 2006), and interpreted 
mildly negative faces as strongly negative (Derntl, Kryspin-Exner, Fernbach, Moser, & Habel, 
2008).  Studies of daily moods also reported increased negative moods during the luteal phase 
than the follicular phase (Allen, Allen, & Pomerleau, 2009; Reed, Levin, & Evans, 2008; Sanders, 
Warner, Backstrom, & Bancroft, 1983).  Because these studies cannot discriminate the effects of 
the two ovarian hormones, we review studies examining estrogen and progesterone separately in 
the following sections. 
Estrogen Decreases Reactions to Emotionally Negative Stimuli 
Animal studies indicate estrogen decreases reactions to emotionally negative stimuli.  For 
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example, exogeneous estrogen administration decreases release of stress hormones at least when 
estrogen does not reach supra-physiological levels (Dayas, Xu, Buller, & Day, 2000; Young, 
Altemus, Parkison, & Shastry, 2001).  Estrogen administration to the amygdala also reduces 
anxiety or depression related behaviors (Frye, Rhodes, & Dudek, 2005; Walf & Frye, 2006).  
Similar patterns were observed in studies in humans as well (e.g., Gasbarri et al., 2008).  
Higher level of estrogen was associated with poorer performance in recognizing anger faces 
(Guapo et al., 2009).  Estrogen therapy is also known to decrease depressive symptoms at least 
in perimenopausal females (Cohen et al., 2003; Soares, Almeida, Joffe, & Cohen, 2001).   
Furthermore, Goldstein et al. (2005) compared brain activity while viewing negative or neutral 
pictures during the early follicular (low estrogen and low progesterone) vs. late follicular phase 
(high estrogen and low progesterone).  As shown in previous studies collapsing sex and 
menstrual cycle phases (e.g., Ochsner et al., 2004; Phan, Wager, Taylor, & Liberzon, 2002), 
females in both phases showed enhanced activity in emotion related regions, such as the 
amygdala and orbitofrontal cortex (OFC), when viewing negative pictures than neutral pictures.  
However, the activity of these areas was modulated by the menstrual cycle phases.  That is, 
females showed greater activity in the amygdala and OFC to negative pictures during the early 
follicular phase than during the late follicular phase (see also Goldstein, Jerram, Abbs, 
Whitfield-Gabrieli, & Makris, 2010). 
Thus, both animal and human studies suggest that reactions to negative stimuli are 
inhibited by estrogen.  Although different studies employed different tasks or measures (e.g., 
amygdala activity to negative pictures, facial emotion recognition), they have observed consistent 
patterns, suggesting that estrogen has similar effects across different aspects of reactions to 
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negative stimuli.  However, this does not mean that estrogen inhibits any tasks involving 
negative stimuli.  In fact, recent research has revealed the facilitative effects of estrogen on one 
type of learning involving negative stimuli -- extinction of fear conditioning (Milad, Igoe, 
Lebron-Milad, & Novales, 2009; Milad et al., 2010; Zeidan et al., in press).   
One possible factor contributing to the contradictory findings is the complexity of tasks 
being employed.  While studies showing inhibitory effects of estrogen measured relatively 
simple reactions to negative stimuli (e.g., amygdala activity to negative pictures; facial emotion 
recognition), extinction learning requires multiple types of processing.  For instance, recent 
research indicates that extinction of fear conditioning involves reward-related learning 
(Holtzman-Assif, Laurent, & Westbrook, 2010; Raczka et al., 2011).  Thus, the facilitative 
effects of estrogen on extinction recall might be caused by the effects of estrogen on reward.  
Furthermore, extinction of conditioning depends not only on emotion-related areas (e.g., OFC), 
but also on the hippocampus (Milad et al., 2007), which increases in volume when estrogen is 
high (Protopopescu et al., 2008).  Thus, structural changes in brain regions critical for extinction 
learning may also explain enhancing effects of estrogen on extinction.  Taken together, it 
appears that estrogen inhibits reactions to negative stimuli, but can have facilitative effects when 
tasks involve reward-related components or hippocampus-related processing. 
Progesterone Enhances Reactions to Emotionally Negative Stimuli 
In contrast with estrogen's inhibitory effects on reactions to negative stimuli, past studies 
suggested that progesterone facilitates reactions to negative stimuli at least in humans (e.g., 
Andreano, Arjomandi, & Cahill, 2008; Protopopescu et al., 2005).  When females were tested at 
two timepoints with different level of progesterone, for example, they experienced more 
 
Running head: EMOTION, REWARD, MENSTRUAL CYCLE 15
 
spontaneous intrusive recollections about unpleasant events when progesterone was high than 
when progesterone was low (Ferree & Cahill, 2009; Ferree, Kamat, & Cahill, in press).  
Similarly, compared to the late follicular phase (high estrogen and low progesterone), females in 
the luteal phase (high estrogen and high progesterone) were more sensitive to facial cues 
signaling contagion and physical threat (Conway et al., 2007) and increased their heart rates more 
while watching negative videos (Ossewaarde et al., 2010).  Furthermore, a neuroimaging study 
(Andreano & Cahill, 2010) revealed increased amygdala activity to negative pictures (relative to 
neutral pictures) when progesterone was high than when progesterone was low.   
Human studies employing exogenous progesterone administration also confirmed the 
facilitative role of progesterone.  For example, females in the follicular phase showed increased 
amygdala activity to angry and fearful faces when they were given progesterone compared with 
placebo (van Wingen et al., 2008).  Progesterone administration also increased physiological 
reactions to a stress task both in males (Childs, Van Dam, & Wit, 2010) and females (Roca et al., 
2003).  Furthermore, exogenous progesterone increased negative moods in women in the early 
follicular phase (Klatzkin, Leslie Morrow, Light, Pedersen, & Girdler, 2006; Soderpalm, Lindsey, 
Purdy, Hauger, & de Wit, 2004) as well as in postmenopausal women (Andréen et al., 2009).  
Taken together, it appears that progesterone increases reactions to negative stimuli in humans.   
However, animal studies provided contradictory findings (Wirth, 2011).  That is, 
exogeneous progesterone administration was revealed to decrease anxiety or depression related 
behaviors (Auger & Forbes-Lorman, 2008; Frye & Walf, 2004; Llaneza & Frye, 2009).  
Furthermore, some studies in humans also observed that progesterone administration weakened 
subjective reactions to negative stimuli (e.g., Childs, Van Dam et al., 2010; de Wit, Schmitt, 
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Purdy, & Hauger, 2001). 
One possible reason for this inconsistency is that while increases in progesterone seen 
during normal menstrual cycles facilitate reactions to negative stimuli (as we discussed above), 
concentrations of progesterone higher than the normal range might decrease emotional reactions 
and have calming effects (see Andréen et al., 2009 for a review).  In fact, when progesterone 
was administered to post menopausal women, participants reported the highest negative mood 
scores with a moderate level of oral micronized progesterone (Andréen, Sundström-Poromaa, 
Bixo, Nyberg, & Bäckström, 2006).  In contrast, both lower and higher concentrations of 
progesterone produced less negative moods (see Figure 2; Andréen et al., 2006).  Thus, it 
appears that the effects of progesterone follow an inverse-U function, rather than a linear 
correlation.  Perhaps, if there is too much progesterone, progesterone no longer has facilitative 
effects and inhibits reactions to negative stimuli (see also Andréen et al., 2005; Gomez, 
Saldivar-Gonzalez, Delgado, & Rodriguez, 2002).  This might explain why studies with 
exogenous progesterone administration to animals and humans sometimes revealed inhibitory 
effects of progesterone on reactions to negative stimuli. 
Summary 
Studies reviewed in this section indicate that estrogen and progesterone have opposing 
influences on reactions to emotionally negative stimuli.  In other words, reactions to negative 
stimuli appear to be inhibited by estrogen but facilitated by progesterone.  These patterns were 
observed across different studies employing different types of tasks or measures (e.g., amygdala 
activity to negative pictures; stress hormones; facial emotion recognition).  However, studies 
sometimes observed different patterns.  Potential factors for these inconsistencies are an inverse 
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quadratic function of progesterone’s effects, reward-related components involved in tasks being 
employed, and structural changes of the brain across the menstrual cycle. 
fects of Ovarian Hormones on Reactions to Emotionally Positive Stimuli 
The amygdala, a key region for emotional processing, responds to emotionally arousing 
information, regardless of whether it is positive or negative (e.g., Anderson et al., 2003; 
Kensinger & Schacter, 2006; Sergerie, Chochol, & Armony, 2008).  Thus, one might expect that 
estrogen and progesterone have similar influences on positive and negative stimuli.  However, 
previous studies in humans provided mixed results regarding ovarian hormone effects on 
reactions to positive stimuli. 
Consistent with facilitative effects of progesterone on reactions to negative stimuli, for 
example, progesterone administration increased positive emotional states in postmenopausal 
women (de Wit et al., 2001).  Higher progesterone was also associated with a greater increase in 
cortisol after positive emotion induction in males (Wirth, Meier, Fredrickson, & Schultheiss, 
2007).  However, opposite patterns have also been reported.  That is, progesterone 
administration reduced amygdala activity to happy or neutral faces (van Wingen et al., 2007) and 
decreased positive emotional states, such as friendliness or confidence, in females in the early 
follicular phase (de Wit et al., 2001; Klatzkin et al., 2006).  Results on estrogen were also mixed.  
Researchers sometimes observed increased activity in emotion-related areas to positive stimuli 
when estrogen was low than high (Zhu et al., 2010).  However, other research provided 
evidence for facilitative effects of estrogen on reactions to positive stimuli (Amin, Epperson, 
Constable, & Canli, 2006; Gizewski et al., 2006). 
One possible reason for this inconsistency is the role of reward.  Although rewards and 
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emotionally positive stimuli can be defined separately (as discussed above), they also overlap 
with each other.  For example, positive but non-rewarding stimuli activate reward-related 
regions, such as striatum, in addition to the amygdala (Hamann & Mao, 2002).  Recent research 
also revealed that viewing positive emotional stimuli can increase subsequent striatum activity to 
monetary rewards (Wittmann, Schiltz, Boehler, & Duzel, 2008).  These results suggest that 
positive emotional stimuli not only evoke physiological arousal through the amygdala, but also 
prime reward-related processing. 
This complex nature of positive stimuli might explain the mixed findings of estrogen and 
progesterone on reactions to positive stimuli.  That is, estrogen might facilitate reward-related 
aspects of reactions to positive stimuli, but inhibit their arousal-related aspects.  Similarly, 
progesterone might inhibit reward-related aspects of reactions to positive stimuli, but have 
facilitative effects on their arousal-related aspects.  Thus, ovarian hormones might have 
opposing influences on the reward-related and arousal-related aspects of positive emotion, which 
could result in unclear effects of the ovarian hormones on reactions to positive stimuli. 
estions for Future Research and Conclusions  
In summary, the current paper suggests that estrogen and progesterone have opposing 
influences on both reactions to emotionally arousing negative stimuli and reactions to rewarding 
stimuli.  In other words, reactions to negative stimuli seem to be inhibited by estrogen, but 
facilitated by progesterone.  In contrast, the opposite effects were observed in reactions to 
rewarding stimuli.  That is, it appears that estrogen facilitates reactions to rewards, while 
progesterone inhibits reactions to rewards not only by itself, but also by countering the facilitative 
effects of estrogen.  In addition to this overall pattern, the current paper also highlights several 
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important questions for future studies.  
The first question concerns the effects of the ovarian hormones on reactions to positive 
stimuli.  As we pointed out in the previous section, past studies reported mixed findings on the 
effects of estrogen and progesterone on reactions to positive stimuli.  Given a potential link 
between reward and positive emotion (e.g., Wittmann et al., 2008), reactions to positive stimuli 
might reflect not only arousal-related processing, but also reward-related processing.  Future 
studies should tease apart these two aspects of positive emotion to clarify how the ovarian 
hormones modulate reactions to positive stimuli.  
A second question is which aspects of reward and emotion are affected by estrogen and 
progesterone.  Studies reviewed in this paper demonstrated that estrogen and progesterone have 
similar influences on the two aspects of reward (Berridge & Robinson, 2003; Berridge et al., 
2009): a) incentive salience (e.g., "want more"; Gray et al., 2010; Justice & De Wit, 2000a; White 
et al., 2002) and b) hedonic consequence (e.g., "like drug"; Evans & Foltin, 2006; Justice & De 
Wit, 2000a).  However, these two aspects often correlate with each other (e.g., Epstein et al., 
2004).  Thus, it is possible that the ovarian hormones influence only one of the aspects, and that 
the affected aspect modulates the other one, which results in similar patterns between them.  
Likewise, although previous research on negative emotion observed similar effects of the ovarian 
hormones across different aspects of emotional reactions (e.g., amygdala activity; stress hormone, 
subjective mood states), there might be some aspects that received stronger effects of the ovarian 
hormones than others.  Future studies need to clarify what aspects of emotional and reward 
reactions are modulated by the ovarian hormones, while considering detailed neurobiological 
mechanisms of the influences of estrogen and progesterone (e.g., Hudson & Stamp, 2011; 
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Quinones-Jenab & Jenab, 2010). 
Another question for future research is how ovarian hormones influence social behaviors or 
one's personality.  The construct of personality relies on the assumption that individuals can be 
characterized by qualities that are relatively invariant over time.  However, many personality 
traits are related with emotion or rewards (e.g., trait anxiety, neuroticism, self-esteem, and reward 
sensitivity).  Thus, the same woman might show cyclic variations in their emotion-related or 
reward-related personality tendencies.  Similarly, the ovarian hormones might influence 
within-individual processes and social behaviors, such as emotion regulation, well-being, 
consumption behaviors, and attitudes toward other people, all of which are relevant to emotion or 
reward.  Future studies need to address the effects of the ovarian hormones on those complex 
intra- and inter-personal processes, while combining traditional psychology research methods 
(e.g., personality assessment, behavioral experiment), with physiological measures (e.g., hormone 
assay) and neuroimaging methods.  This multimethodological approach should provide better 
understanding of our behaviors in everyday life. 
In conclusion, from the studies included in this review, it appears that the menstrual cycle 
and ovarian hormones modulate how people react to emotional and rewarding stimuli.  Given 
the core importance of emotion and reward processing in our lives, such differences are important 
and further investigation is needed to better understand the mechanisms of the effects.  These 
hormonal effects might explain why specific phases of the cycle are related to depressive 
symptoms (Farage, Osborn, & MacLean, 2008) or higher risks in addiction (Becker & Hu, 2008; 
Terner & de Wit, 2006).  Thus, examining the effects of menstrual cycle or ovarian hormones 
may have theoretical implications in many fields, while providing practical suggestions on how 
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to improve females’ well-being in real life. 
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Figure Captions 
Figure 1.  The human menstrual cycle.  Day 1 of the cycle is defined as the first day of 
menstruation, with ovulation occurring on day 14 in a typical 28-day cycle.  The follicular phase 
starts on day 1 and continues until ovulation, which is followed by the luteal phase.  The 
menstrual cycle in healthy women is associated with A) pituitary hormone changes, B) 
development of ovarian follicles, C) changes in estrogen and progestrone level, and D) changes 
in the thickness of the uterine lining (Adapted from Vincent & Tracy (2010) and Merck at 
http://www.merckmanuals.com/home/sec22/ch238/ch238e.html?qt=estrogen%20progestrone%20
&alt=sh). 
Figure 2. Effects of progesterone on negative mood in postmenopausal women (Andreen et 
al., 2006).  Participants showed more negative mood with a moderate level of allopregnanolone 
(i.e., a metabolite of progesterone) than with a higher or lower level. 
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